Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.

A. Miya, M. Yamamoto, H. Morimoto, N. Tanaka, E. Shin, K. Karakawa, K. Toyoshima, Y. Ishizaka, T. Mori, S. Takai

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)

Abstract

We studied the expression of the ret proto-oncogene (proto-ret) in human medullary thyroid carcinomas (MTCs) and pheochromocytomas of multiple endocrine neoplasia type 2A (MEN 2A) by Northern blot analysis. Expression of the normal-sized transcripts was detected in all 12 MTCs and in 6 of 8 pheochromocytomas. In situ localization of proto-ret mRNA revealed that the signal was confined to the cytoplasm of MTC cells. By Southern blot analysis neither amplification nor gross genetic changes of proto-ret were found in the tumors. Although no transcripts were detected in the normal portion of the thyroid from one MEN 2A patient, faint signals were detected in normal adrenal glands by Northern blot analysis, probably due to minor populations of C-cells and chromaffin cells in specimens from which MTC and pheochromocytoma might later develop. Proto-ret may play an important role in differentiation of a specific cell lineage from neuroectoderm, and it may be involved in development of MEN 2A tumors.

Original languageEnglish
Pages (from-to)215-219
Number of pages5
JournalHenry Ford Hospital Medical Journal
Volume40
Issue number3-4
Publication statusPublished - 1992

Fingerprint

Dive into the research topics of 'Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.'. Together they form a unique fingerprint.

Cite this